Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial

by Thomas Hutson, Peter Van Veldhuizen, Michael R Harrison, Scott S Tykodi, Daniel J George, Lucio N Gordan, Robert S Alter, Edward Arrowsmith, Ivor Percent, Rakesh Singal, Joshua Zhang, Jesus Zoco, Jennifer L Johansen, Arash Rezazadeh Kalebasty
Published 2022-02-01

599 Single-agent safety and activities of target-preserving anti-CTLA-4 antibody gotistobart (ONC-392/BNT316) in PD-(L)1 resistant metastatic NSCLC and population PK analysis in pa...

by Yang Liu, Dan Chen, Mark Goldstein, John Yang, Mei Tang, Rohit Joshi, David Carbone, Siwen Hu-Lieskovan, Zihai Li, Tianhong Li, Meredith McKean, Kai He, Julio Peguero, Pan Zheng, Hung-Yen Chou, Edward Arrowsmith, John Hamm, AIwu He, Satish Shah, Alexander I Spira, Rama Balaraman, Adriana millillo-Naranine
Published 2023-11-01